EBMT 2019 | MRD negativity in ALL

Dieter Hoelzer

Dieter Hoelzer, MD, PhD, from the University of Frankfurt, Frankfurt, Germany, explores the importance of MRD negativity in acute lymphoblastic leukemia (ALL). Dr Hoelzer was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video